Given the negative effect of delayed allograft function Background. Allograft survival among black recipients on allograft survival, efforts to identify its modifiable is poorer than among whites. Delayed allograft func-risk factors should be a high priority. tion is associated with a significant reduction in renal allograft survival. The relationship between delayed allograft function and black race is incompletely speci-Key words: cadaveric allograft; delayed allograft fied and was the focus of this investigation.
provider. The designation was the same as that recorded by the United States Health Care Financing Administration and The 389 of 392 consecutive recipients of cadaveric renal the United States Renal Data System for each of our subjects. allografts (without a pancreatic allograft) transplanted between 1 January 1985 and 31 December 1990 at the
Data collection
University of Pennsylvania Medical Center for whom the occurrence of DGF could be ascertained were potentially Data on cadaveric renal allograft donors were obtained from eligible for study. We excluded 51 recipients who lost their the Delaware Valley Transplant Program, the local organ allograft during the first post-transplant month to be certain procurement organization. Donor HLA-A, B, and DR antito exclude patients who experienced hyperacute rejection or gens, sex, age, race, and cold ischaemia time were recorded. allograft failure secondary to technical surgical failure.
Recipient study data were abstracted from medical records Thirteen recipients who were of neither white nor black race at the University of Pennsylvania Medical Center and were also excluded, resulting in 325 recipients who were included recipient HLA antigen type, age, race, sex, underincluded in the study.
lying cause of renal failure, duration of end-stage renal disease ( ESRD), number of prior transplants, antirejection therapy, number of prior blood transfusions, and duration
Organ procurement of allograft function.
All renal allografts were procured using standard multiorgan Analytical methods intravascular flush techniques and were preserved at 4°C until implantation. Pulsatile perfusion was not used in this We compared the proportion of patients who experienced study. In most cases, Euro-Collins solution was used to flush DGF among white and black recipients. In addition, we the aorta of the donors and cold store the harvested kidneys.
explored the relationship of DGF with potentially confounding variables such as gender, donor and recipient ages, T-cell panel reactive antibody (PRA), cold ischaemia time, HLA matches, duration and cause of ESRD, and history of Immunosuppression prior kidney transplantation. This was achieved by calculating unadjusted odds ratios and 95% confidence intervals for All study subjects were treated with an immunosuppressive each variable, using logistic regression in which DGF was regimen that included corticosteroids and cyclosporin. One the dependent variable [22] . For all continuous variables gram of intravenous methylprednisolone was administered such as age, PRA, and cold ischaemia time, we used models intraoperatively followed by prednisone 1.5 mg/kg/day incorporating actual values of the variables and others tapered to 0.5 mg/kg/day by the day of discharge. In 1985 incorporating ordinal representations based on quartiles. We and 1986, cyclosporin was begun on the first postoperative applied a log transformation to the variable, length of prior day at a dose of 14 mg/kg/day with dose modifications to renal replacement therapy (RRT ), to create a normally maintain a whole blood trough level, measured by highdistributed form of the variable [23] . All other continuous pressure liquid chromatography, between 100 and 200 mg/l.
variables were normally distributed without transformation. When allograft function was delayed, cyclosporin dosing was
In addition, we examined models with both linear and reduced to 7 mg/kg/day. With resumption of renal function, quadratic terms for interval scale variables to allow for nonthe cyclosporin dose was increased and adjusted according linear relationships with DGF. No quadratic terms achieved to trough blood levels. In 1987 azathioprine was added to statistical significance, and therefore these were excluded cyclosporin and corticosteroids for maintenance immunosupfrom our final models [23] . pression. Beginning in 1988, cyclosporin therapy was held
To assess for confounding and interaction we performed ('cyclosporin-sparing therapy') for selected (n=27) patients a multivariate analysis. We used multivariate logistic regreswith oliguria immediately after transplantation until after sion to confirm the relationship between recipient race and administration of peritransplant antibody therapy with DGF and to assure the stability of the univariate analysis Orthoclone, Ortho Pharmaceutical, Raritan, NJ (OKT3) by adjusting for confounding variables. Using standard (n=71) or ATGAM (n=1) (ATGAM, Upjohn Company, methods, we calculated odds ratios for study variables in our Kalamazoo, MI ). Antibody therapy began on the first postmodels and reported these with 95% confidence intervals and transplant day and was administered during the first 1-2 two-sided P values [22] . We excluded all cases who had weeks following transplantation.
missing values for any of the study variables. Because of the exclusion of subjects with missing data from this multivariate analysis, we anticipated reduced precision (i.e. a wider con-
Definition of delayed graft function
fidence interval around the point estimate of the odds ratio and a higher P value). Therefore, we used the multivariate Delayed renal allograft function (DGF ) was defined as analysis primarily to confirm that the point estimate of the treatment with either haemodialysis or peritoneal dialysis odds ratio from the unadjusted analysis (using all study during the first week following transplantation. Only patients subjects) was valid and not confounded by other factors with immediate severe allograft dysfunction not attributable related to DGF. We also used multivariate models to explore to acute rejection were identified as having DGF. All patients interactions between race and other predictors of allograft experiencing DGF whose renal function did not spontan-survival. eously improve within 7-10 days underwent transplant
To assure the stability of the results, we performed several ancillary analyses. First, we examined the potential biopsy to diagnose occult acute rejection.
H. I. Feldman et al. 706 confounding influence of delaying cyclosporin therapy until
The characteristics of donor kidneys transplanted after administration of peritransplant antibody therapy. We into study subjects are summarized in Table 2 . The accomplished this by including a term indicating delayed vast majority of kidneys were harvested from white administration of cyclosporin and also by fitting our models donors. The mean (SD) donor age was 29.4 (15.4) after excluding the 27 patients who received delayed cyclospo-years. There was, in general, a low degree of HLA rin. Second, we imputed values for missing data so that all antigen matching among study subjects. Two hundred 325 subjects could be included in the multivariate analysis. forty-nine (76.6%) transplant kidneys were mismatched
For missing values, we substituted the mean for continuous to recipients at 4 or more HLA antigens. Only 76 variables and the mode for categorical variables. Two addi-(23.4%) kidneys were mismatched to recipients at 3 or tional models with relaxed exclusion criteria were fit, first excluding only patients whose allografts were lost due to fewer loci. The mean (SD) cold ischaemia time was technical complications during the first 2 weeks after trans-30.2 h (8.6 h).
plantation and then excluding no subjects, on this basis.
Finally, we also built models using an alternative definition Unadjusted analyses of DGF: a serum creatinine >2.5 at 2 weeks after transplantation.
The percentage of blacks who experienced DGF was 62.6% compared to 48.3% of whites. The odds ratio for DGF comparing blacks to whites was 1.80 (95% Results CI 1.09,2.95), P=0.02. The unadjusted odds ratios for potentially confounding study variables are presented in Table 3 . Diabetes mellitus as the cause of ESRD Description of the study cohort (P=0.03), increasing cold ischaemia time (0.04), The demographic characteristics of the 325 renal allo-increasing donor age (P=0.01), length of renal replacegraft recipients included in the study are summarized ment therapy (P=0.01), T-cell PRA (P=0.03), and in Table 1 . Ninety-one (28%) subjects were black and prior blood transfusions (P=0.01) were all also signi-234 (72%) were white. One hundred and seventy ficantly associated with the occurrence of DGF in (52.3%) of our subjects experienced DGF. Fifty-three unadjusted analyses. (16.3%) patients had diabetes mellitus as the cause of their ESRD, 40 (12.3%) had hypertension, and 114 Assessment of confounding and interactions (35.1%) had glomerulonephritis. The mean age of recipients (standard deviation (SD)) was 40.9 (12.0) The stability of the race:DGF association was evaluated in multivariate models adjusting for each of the years. The mean (SD) T-cell PRA was 11.5% (24.5%) with 67.1% of the cohort having a PRA of 0%.
variables predictive of DGF in the univariate analysis Owing to missing data on covariates, only 210 individuals were included in these models, substantially to large amounts of missing data for prior blood reducing their precision and causing widening of the and prior transplantation as important risk factors for DGF. These findings were stable over a broad array confidence intervals. Nonetheless, these models demonstrate that findings from the unadjusted models did of sensitivity analyses including an analysis that examined less severe DGF defined by persistent elevations not result from uncontrolled confounding. The odds ratios for recipient race among these 210 recipients of serum creatinine and not simply the need for peritransplant dialytic therapy. These findings suggest a were OR=1.69 (95% CI, 0.93, 3.10) for unadjusted analysis and OR=1.74 (95% CI 0.91, 3.34) for adjusted potential mechanism through which black race is associated with shortened allograft survival and importanalysis. The similarity between the unadjusted result among the 210 patients without missing data and the antly, an underexplored area for potential interventions to improve allograft outcomes among black recipients. unadjusted result among all 325 study subjects shows that the subgroup with complete data is representative This study's findings are consistent with prior studies [5, 8, 13] that have suggested higher rates of DGF of the larger group with respect to the race5DGF relationship. Further, the similarity between the unad-among blacks. Sanfilippo and colleagues [8] studied over 3800 cadaveric renal transplant recipients between justed and adjusted analysis (among 210 patients without missing data) confirms that the unadjusted 1977 and 1982, prior to the use of cyclosporin. In multivariate adjusted analyses, black race was a signirelationship between race and DGF is valid and not confounded by other factors related to DGF. Therefore ficant predictor of DGF, among patients receiving their first transplant. Few studies are available examinthe best expression of the precision (confidence interval and P value) of the race:DGF odds ratio should be ing the relationship between race and DGF in the era of cyclosporin, and those available have not adjusted derived from the analysis of all 325 study subjects.
Using the alternative definition for DGF of creatin-for potential confounding factors [5, 13] . Cacciarelli and colleagues [5] studied 495 cadaveric allograft ine >2.5 mg/dl at 2 weeks, black race continued to be a significant but more potent predictor of DGF, recipients between 1983 and 1987, all of whom received cyclosporin. Fifty-eight per cent of 176 black recipients adjusted OR=2. 17 (95% CI, 1.11, 4.18). Imputing values for missing data so as to include all 325 subjects required dialysis post-transplant compared to 46% of 221 white recipients, a difference that was statistically in a multivariate model yielded similar results, adjusted OR=1.85 (95% CI, 1.09, 3.13). The ancillary analyses significant (P<0.05) in unadjusted analyses. Koyama and colleagues [13] also studied DGF among patients examining the confounding influence of delayed cyclosporin therapy until after administration of peritranspl-transplanted between October 1987 and December 1991. In their unadjusted analysis, 34% of black recipiant antibody therapy also yielded results similar to our principal analysis. The OR for black race compared ents required dialysis, as compared to 22% of white recipients. to white race adjusted for delay in cyclosporin therapy was 1.75 (95% CI, 1.06, 2.86) and when we excluded
The importance of a recipient race relationship to the occurrence of DGF should be evaluated in the 27 subjects whose cyclosporin therapy was delayed, the adjusted OR for black race compared to white race context of allograft survival differences between races.
Prior research has consistently demonstrated between of 2.13 (95% CI, 1.03, 4.35). The ancillary analyses that excluded subjects with allografts lost due to tech-11% and 15% lower 2-year renal allograft survival rates among black recipients compared to white recipinical complications during the initial 2 weeks posttransplantation or excluded no subjects on this basis ents [12, 15, 16, 18] . Potential explanations considered have included a greater number of HLA mismatches also produced similar results (data not shown). Additionally, there were no significant relationships [19, 20] , greater immune responsiveness in black recipients [21] , and poor drug compliance [24] [25] [26] [27] [28] . Given between race and either gender of the recipient or the maximum cyclosporin level during the first week post-the consistency with which a substantive negative impact of DGF on renal allograft survival has been transplant. Similarly, there were no significant relationships between DGF and either gender or cyclosporin reported [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] , this study provides evidence for a potentially underexplored mechanism explaining, in levels. Finally, no interactions between recipient race and other predictors of DGF were detected. part, poor allograft survival among blacks. The fact that prior transplantation and PRA at A number of other factors, including older donor age, diabetes, and prior transplantation, remained times have been related to DGF [1] [2] [3] [4] 6, 8, 12] suggests that the pathophysiology of DGF may, in part, be important predictors of DGF in our adjusted multivariate model, and are described in Table 4 . Cold ischaemia immunologically based. Although still controversial, some investigators have suggested that the immune time, T-cell PRA, and length of prior renal replacement therapy were no longer statistically significant but, as responsiveness of black ESRD patients is greater than that of white ESRD patients. This may arise from less noted above, this model had reduced precision resulting from missing data.
complete HLA matching of black transplant recipients to donors at minor histocompatibility determinants not currently measured during histocompatibility test-
Discussion
ing. Alternatively, Kerman et al. [21] postulated an inherently greater immune responsiveness among blacks compared to whites. Regardless of the cause, a This study demonstrates that black race joins the previously established factors of cold ischaemia time greater immune reactivity among blacks may be associated with greater early immune injury and a cyclosporin suggest these findings were not directly attributable to cyclosporin nephrotoxicity. In addition, higher rate of DGF consistent with our study's findings. Examination of these potential immunological the stability of these findings for both severe (dialysis requiring) and less severe definitions of DGF are mechanisms, however, was beyond the scope of our study, despite there having been no difference in cyclo-supportive of an important effect of race on the functioning of cadaveric renal allografts immediately sporin levels across race.
Alternative explanations for a greater rate of DGF after transplantation. In summary, this study has demonstrated that black among black recipients conceivably relate to lesser bioavailability of cyclosporin among blacks compared race is an important risk factor for DGF. The role of DGF as a mediator of the consistently observed poorer to whites [29] . While such reductions in bioavailability have been associated with poorer long-term allograft allograft survival among blacks deserves further exploration. These findings also present a strong outcomes [30] , it is plausible that they may also facilitate potential immunological mechanisms of impetus for research identifying strategies to prevent DGF and improving allograft outcomes among black DGF.
In addition to black race, this study's results were recipients. Similarly, the development of treatment strategies for allograft recipients experiencing DGF consistent with prior reports of predictors of DGF, including prolonged cold ischaemia time, increased that will reduce its negative impact on long-term allograft survival are likely to bring particular benefit donor age, prior transplantation, lengthy durations of prior dialysis therapy, higher T-cell PRA, and prior to black transplant patients. blood transfusions. Although several of these factors did not retain statistical significance in our multivariate Acknowledgements. We gratefully acknowledge the expert assistance and support we received from Beth Cameron RN, Chris Chmielewski models, missing data on covariates for a substantial RN, Terri Holland RN, and Jan McIlvane. subset of patients limited the power of these analyses.
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Although we found no significant relationship between hypertension and DGF, we found that black recipients were significantly more likely to have been References diagnosed as having hypertensive renal disease than 
